Based on the previous reports and findings, we thereby hypothesized that MSCs-derived exosomes could deliver miR-199a to glioma cells and thus prevent the tumorigenic progression of glioma via the down-regulation of AGAP2. The gene discussed is AGAP2; the disease is central nervous system cancer.